The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective study
Francesco Salerno(IRCCS Policlinico San Donato), M.A. Manini(University of Milan), Rosa G Simonetti(Ospedale Vincenzo Cervello), Milena Arghittu(Agenzia Sanitaria e Sociale Regionale), Mauro Borzio(Ospedale Papa Giovanni XXIII), Daniela Dalla Gasperina(Unknown), Irene Cacciola(University of Messina), Clara Dibenedetto, Andrew K. Burroughs(University College London), Claudia Pedicino(ASST Melegnano e della Martesana), Vincenzo La Mura(University of Milan), Mauro Bernardi(Universidad Nacional de La Pampa), Sergio Boccia(Arcispedale Sant'Anna), Angelo Rossini(Centro Universitário Barão de Mauá), P Angeli(University of Padua), E. Dionigi(ASST Melegnano e della Martesana)
Cited by 76
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
|Journal of Hepatology|2015|864
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631